Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression-Reference-Cited by-同舟云学术

Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression

Published:2013-03 Issue:2 Volume:5 Page:255-262
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Buchanan Andrew,Clementel Veronica,Woods Rob,Harn Nicholas,Bowen Michael A,Mo Wenjun,Popovic Bojana,Bishop Steven M.,Dall’Acqua William,Minter Ralph,Jermutus Lutz,Bedian Vahe

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.23392

Reference42 articles.

1. Erythropoietin-Associated PRCA: Still an Unsolved Mystery

2. Fatal Infusion Reactions to Cetuximab: Role of Immunoglobulin E–Mediated Anaphylaxis

3. Immunogenicity, efficacy and adverse events of adalimumab in RA patients

4. Aggregation, stability, and formulation of human antibody therapeutics

5. High-throughput measurement of protein stability in microtiter plates

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability of Protein Pharmaceuticals: Recent Advances;Pharmaceutical Research;2024-06-27

2. Effect of Free Cysteine Residues to Serine Mutation on Cellodextrin Phosphorylase;Journal of Applied Glycoscience;2024-05-20

3. LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies;PLOS Computational Biology;2024-03-05

4. Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants;Cell Reports;2023-05

5. Assessing developability early in the discovery process for novel biologics;mAbs;2023-02-23